Zumla, A. et al. The 2024 Public Health Emergency of International Concern: a global failure to control mpox. Am. J. Trop. Med. Hyg. 112, 17–20 (2025).
Eurosurveillance Editorial Team. Note from the editors: WHO declares mpox outbreak a public health emergency of international concern. Eurosurveillance 29, 240815v (2024).
Ndembi, N. et al. Mpox outbreaks in Africa constitute a public health emergency of continental security. Lancet Glob. Health 12, e1577–e1579 (2024).
Bunge, E. M. et al. The changing epidemiology of human monkeypox — a potential threat? A systematic review. PLoS Negl. Trop. Dis. 16, e0010141 (2022).
Allan-Blitz, L. T. & Klausner, J. D. Current evidence demonstrates that monkeypox is a sexually transmitted infection. Sex. Transm. Dis. 50, 63 (2022).
Allan-Blitz, L. T. et al. A position statement on mpox as a sexually transmitted disease. Clin. Infect. Dis. 76, 1508–1512 (2023).
León-Figueroa, D. A. et al. Epidemiological situation of monkeypox transmission by possible sexual contact: a systematic review. Trop. Med. Infect. Dis. 7, 267 (2022).
Tomori, O. & Ogoina, D. Monkeypox: the consequences of neglecting a disease, anywhere. Science 377, 1261–1263 (2022).
Adetifa, I., Muyembe, J. J., Bausch, D. G. & Heymann, D. L. Mpox neglect and the smallpox niche: a problem for Africa, a problem for the world. Lancet 401, 1822 (2023).
Simpson, K. et al. Human monkeypox — after 40 years, an unintended consequence of smallpox eradication. Vaccine 38, 5077–5081 (2020).
Wick, J. M., Pelliccione, A., Tran, H. N. & Skarbinski, J. Concurrent sexually transmitted infections with mpox infections: a brief review. Perm. J. 28, 42–45 (2024).
Silva, M. S. T. et al. Mpox, sexually transmitted infections and combination prevention: insights from a major cohort in Rio de Janeiro, Brazil. AIDS 38, 1845–1849 (2024).
Magnus, P., von, Andersen, E. K., Petersen, K. B. & Birch-Andersen, A. A pox-like disease in cynomolgus monkeys. Acta Path. Microbiol. Scand. 46, 156–176 (1959).
Ladnyj, I. D., Ziegler, P. & Kima, E. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull. World Health Organ. 46, 593–597 (1972).
Lourie, B. et al. Human infection with monkeypox virus: laboratory investigation of six cases in West Africa. Bull. World Health Organ. 46, 633–639 (1972).
Reed, K. D. et al. The detection of monkeypox in humans in the Western Hemisphere. N. Engl. J. Med. 350, 342–350 (2004).
Hoff, N. et al. Evolution of a disease surveillance system: an increase in reporting of human monkeypox disease in the Democratic Republic of the Congo, 2001–2013. Int. J. Trop. Dis. Health 25, 1–10 (2017).
Rimoin, A. W. et al. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc. Natl Acad. Sci. USA 107, 16262–16267 (2010). This pivotal study provides the first strong evidence that mpox incidence had dramatically increased in the DRC, linking the rise to the cessation of routine smallpox vaccination campaigns.
Yinka-Ogunleye, A. et al. Reemergence of human monkeypox in Nigeria, 2017. Emerg. Infect. Dis. 24, 1149–1151 (2018).
Yinka-Ogunleye, A. et al. Outbreak of human monkeypox in Nigeria in 2017–18: a clinical and epidemiological report. Lancet Infect. Dis. 19, 872–879 (2019).
Parker, E. et al. Genomics reveals zoonotic and sustained human mpox spread in West Africa. Nature 643, 1343 (2025).
Ogoina, D. et al. Clinical course and outcome of human monkeypox in Nigeria. Clin. Infect. Dis. 71, E210–E214 (2020).
Ogoina, D. et al. The 2017 human monkeypox outbreak in Nigeria — report of outbreak experience and response in the Niger Delta University Teaching Hospital, Bayelsa State, Nigeria. PLoS ONE 14, e0214229 (2019). This seminal report on the 2017 Nigerian outbreak systematically describes clinical and epidemiological evidence suggesting sexual transmission of mpox, fundamentally altering the understanding of its potential spread.
Mauldin, M. R. et al. Exportation of monkeypox virus from the African continent. J. Infect. Dis. 225, 1367–1376 (2022).
Ogoina, D. & Yinka-Ogunleye, A. Sexual history of human monkeypox patients seen at a tertiary hospital in Bayelsa, Nigeria. Int. J. STD AIDS 33, 1–5 (2022).
Vivancos, R. et al. Community transmission of monkeypox in the United Kingdom, April to May 2022. Eurosurveillance 27, 2200422 (2022).
Vaughan, A. M. et al. A large multi-country outbreak of monkeypox across 41 countries in the WHO European Region, 7 March to 23 August 2022. Eurosurveillance 27, 2200620 (2022).
Thornhill, J. P. et al. Monkeypox virus infection in humans across 16 countries — April–June 2022. N. Engl. J. Med. 387, 679–691 (2022). This case series, one of the first and largest, from the 2022 global outbreak confirms on a global scale the efficient sexual transmission and novel clinical presentations first hinted at in the Nigerian outbreak.
Ndembi, N. et al. Evolving epidemiology of mpox in Africa in 2024. N. Engl. J. Med. 392, 666–676 (2025).
Salomon, I. et al. Monkeypox outbreak in the Democratic Republic of Congo: a comprehensive review of clinical outcomes, public health implications, and security measures. Immun. Inflamm. Dis. 12, e70102 (2024).
Vakaniaki, E. H. et al. Sustained human outbreak of a new MPXV clade I lineage in eastern Democratic Republic of the Congo. Nat. Med. 30, 2791–2795 (2024).
Masirika, L. M. et al. Epidemiological and genomic evolution of the ongoing outbreak of clade Ib mpox virus in the eastern Democratic Republic of the Congo. Nat. Med. 2025, 1–5 (2025).
Brosius, I. et al. Epidemiological and clinical features of mpox during the clade Ib outbreak in South Kivu, Democratic Republic of the Congo: a prospective cohort study. Lancet 405, 547–559 (2025).
Masirika, L. M. et al. Ongoing mpox outbreak in Kamituga, South Kivu province, associated with monkeypox virus of a novel clade I sub-lineage, Democratic Republic of the Congo, 2024. Eurosurveillance 29, 2400106 (2024).
Kibungu, E. M. et al. Clade I-associated mpox cases associated with sexual contact, the Democratic Republic of the Congo. Emerg. Infect. Dis. 30, 172–176 (2024). This crucial report from the DRC documents the first evidence of sexual transmission of the more virulent clade I mpox, signalling a dangerous new phase in the evolution of the virus.
Pareek, A. et al. Global spread of clade Ib mpox: a growing concern. Lancet Microbe 6, 101132 (2025).
Alakunle, E. et al. A comprehensive review of monkeypox virus and mpox characteristics. Front. Cell. Infect. Microbiol. 14, 1360586 (2024).
Alakunle, E., Moens, U., Nchinda, G. & Okeke, M. I. Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution. Viruses 12, 1257 (2020).
McFadden, G. Poxvirus tropism. Nat. Rev. Microbiol. 3, 201–213 (2005).
Moss, B. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2905–2946 (Lippincott Williams & Wilkins, 2007).
Dixon, L. K. & Esposito, J. J. in Field Virology (eds Knipe, D. M. & Howley, P. M.) 2029–2055 (Lippincott Williams & Wilkins, 2010).
Moss, B. & Poxvirus, D. N. A. Replication. Cold Spring Harb. Perspect. Biol. 5, a010199 (2013).
Lum, F.-M. et al. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nat. Rev. Immunol. 22, 597–613 (2022).
Lu, J. et al. Mpox (formerly monkeypox): pathogenesis, prevention and treatment. Signal Transduct. Target. Ther. 8, 1–15 (2023).
Fang, D., Liu, Y., Dou, D. & Su, B. The unique immune evasion mechanisms of the mpox virus and their implication for developing new vaccines and immunotherapies. Virol. Sin. 39, 709–718 (2024).
Zandi, M., Shafaati, M. & Hosseini, F. Mechanisms of immune evasion of monkeypox virus. Front. Microbiol. 14, 1106247 (2023).
Weaver, J. R. & Isaacs, S. N. Monkeypox virus and insights into its immunomodulatory proteins. Immunol. Rev. 225, 96–113 (2009).
Likos, A. M. et al. A tale of two clades: monkeypox viruses. J. Gen. Virol. 86, 2661–2672 (2005).
Happi, C. et al. Urgent need for a non-discriminatory and non-stigmatizing nomenclature for monkeypox virus. PLoS Biol. 20, e3001769 (2022).
Kinganda-Lusamaki, E. et al. Clade I mpox virus genomic diversity in the Democratic Republic of the Congo, 2018–2024: predominance of zoonotic transmission. Cell 188, 4–14.e6 (2025).
Okwor, T., Mbala, P. K., Evans, D. H. & Kindrachuk, J. A contemporary review of clade-specific virological differences in monkeypox viruses. Clin. Microbiol. Infect. 29, 1502–1507 (2023).
Andrei, G. & Snoeck, R. Differences in pathogenicity among the mpox virus clades: impact on drug discovery and vaccine development. Trends Pharmacol. Sci. 44, 719–739 (2023).
Charniga, K. et al. Updating reproduction number estimates for mpox in the Democratic Republic of Congo using surveillance data. Am. J. Trop. Med. Hyg. 110, 561–568 (2024).
Isidro, J. et al. Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus. Nat. Med. 28, 1569–1572 (2022).
Americo, J. L., Earl, P. L. & Moss, B. Virulence differences of mpox (monkeypox) virus clades I, IIa, and IIb.1 in a small animal model. Proc. Natl Acad. Sci. USA 120, e2220415120 (2023).
Otieno, J. R. et al. Global genomic surveillance of monkeypox virus. Nat. Med. 31, 342–350 (2024).
O’Toole, Á et al. APOBEC3 deaminase editing in mpox virus as evidence for sustained human transmission since at least 2016. Science 382, 595–600 (2023). An advanced genomic analysis, this study reveals that the global outbreak strain had been circulating in humans for years, accumulating mutations via APOBEC3 enzymes that probably facilitated its sustained human-to-human transmission.
Gigante, C. M. et al. Multiple lineages of monkeypox virus detected in the United States, 2021–2022. Science 378, 560–565 (2022).
Wawina-Bokalanga, T. et al. Epidemiology and phylogenomic characterisation of two distinct mpox outbreaks in Kinshasa, DR Congo, involving a new subclade Ia lineage: a retrospective, observational study. Lancet 406, 63–75 (2025).
Bonilla-Aldana, D. K. et al. Mpox infection in animals: a systematic review and meta-analysis. J. Infect. Public Health https://doi.org/10.1016/J.JIPH.2024.04.015 (2024).
Khodakevich, L., Jezek, Z. & Kinzanzka, K. Isolation of monkeypox virus from wild squirrel infected in nature. Lancet 1, 98–99 (1986).
Radonić, A. et al. Fatal monkeypox in wild-living sooty mangabey, Côte d’Ivoire, 2012. Emerg. Infect. Dis. 20, 1009 (2014).
WHO recommends new name for monkeypox disease. World Health Organization https://www.who.int/news/item/28-11-2022-who-recommends-new-name-for-monkeypox-disease (2022).
Seang, S. et al. Evidence of human-to-dog transmission of monkeypox virus. Lancet 400, 658–659 (2022).
Morgan, C. N. et al. One Health investigation into mpox and pets, United States. Emerg. Infect. Dis. 30, 2025–2032 (2024).
Hutson, C. L. et al. Transmissibility of the monkeypox virus clades via respiratory transmission: investigation using the prairie dog-monkeypox virus challenge system. PLoS ONE 8, e55488 (2013).
Beeson, A. et al. Mpox respiratory transmission: the state of the evidence. Lancet Microbe 4, e277–e283 (2023).
Learned, L. A. et al. Extended interhuman transmission of monkeypox in a hospital community in the Republic of the Congo, 2003. Am. J. Trop. Med. Hyg. 73, 428–434 (2005).
Pan, D. et al. Transmission of monkeypox/mpox virus: a narrative review of environmental, viral, host, and population factors in relation to the 2022 international outbreak. J. Med. Virol. 95, e28534 (2023).
Morgan, C. N. et al. Environmental persistence of monkeypox virus on surfaces in household of person with travel-associated infection, Dallas, Texas, USA, 2021. Emerg. Infect. Dis. 28, 1982–1989 (2022).
Meschi, S. et al. MPXV DNA kinetics in bloodstream and other body fluids samples. Sci. Rep. 14, 13487 (2024).
Yinda, C. K. et al. Stability of monkeypox virus in body fluids and wastewater. Emerg. Infect. Dis. 29, 2065–2072 (2023).
Banuet-Martinez, M. et al. Monkeypox: a review of epidemiological modelling studies and how modelling has led to mechanistic insight. Epidemiol. Infect. 151, e121 (2023).
Satapathy, P. et al. Potentially asymptomatic infection of monkeypox virus: a systematic review and meta-analysis. Vaccines 10, 2083 (2022).
Marziano, V., Guzzetta, G., Longini, I. & Merler, S. Epidemiologic quantities for monkeypox virus clade I from historical data with implications for current outbreaks, Democratic Republic of the Congo. Emerg. Infect. Dis. 30, 2042–2046 (2024).
Diaz Brochero, C. et al. Decoding mpox: a systematic review and meta-analysis of the transmission and severity parameters of the 2022–2023 global outbreak. BMJ Glob. Health 10, 16906 (2025).
Ponce, L. et al. Incubation period and serial interval of mpox in 2022 global outbreak compared with historical estimates. Emerg. Infect. Dis. 30, 1173 (2024).
Reynolds, M. G. et al. Clinical manifestations of human monkeypox influenced by route of infection. J. Infect. Dis. 194, 773–780 (2006).
Tarín-Vicente, E. J. et al. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study. Lancet 400, 661–669 (2022).
del Río García, V. et al. Monkeypox outbreak in a piercing and tattoo establishment in Spain. Lancet Infect. Dis. 22, 1526–1528 (2022).
Patrono, L. V. et al. Monkeypox virus emergence in wild chimpanzees reveals distinct clinical outcomes and viral diversity. Nat. Microbiol. 5, 955–965 (2020).
Beer, E. M. & Bhargavi Rao, V. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Negl. Trop. Dis. 13, e0007791 (2019).
Ugwu, C. L. J. et al. Risk factors associated with human mpox infection: a systematic review and meta-analysis. BMJ Glob. Health 10, 16937 (2025).
Nakazawa, Y. et al. Mapping monkeypox transmission risk through time and space in the Congo Basin. PLoS ONE 8, e74816 (2013).
Lu, G. et al. Environmental, socioeconomic, and sociocultural drivers of monkeypox transmission in the Democratic Republic of the Congo: a One Health perspective. Infect. Dis. Poverty 14, 7 (2025).
Besombes, C. et al. Seasonal patterns of mpox index cases, Africa, 1970–2021. Emerg. Infect. Dis. 30, 1017 (2024).
Edward, M. Mpox in conflict zones: lessons from displaced populations in the Democratic Republic of Congo (DRC). Glob. Public Health 20, 2551008 (2025).
Kuppalli, K. et al. The worsening mpox outbreak in Africa: a call to action. Lancet Infect. Dis. 24, 1190–1192 (2024).
Breman, J. G., Ruti, K. & Steniowski, M. V. Human monkeypox, 1970–79. Bull. World Health Organ. 58, 165–182 (1980).
World Health Organisation Human monkeypox in West Africa. Wkly Epidemiol. Rec. 54, 1–3 (1979).
Jezek, Z., Szczeniowski, M., Paluku, K. M. & Mutombo, M. Human monkeypox: clinical features of 282 patients. J. Infect. Dis. 156, 293–298 (1987).
Jezek, Z., Grab, B., Szczeniowski, M., Paluku, K. M. & Mutombo, M. Clinico-epidemiological features of monkeypox patients with an animal or human source of infection. Bull. World Health Organ. 66, 459–464 (1988).
Fenner, F., Henderson, D. A., Arita, I., Jezek, Z. & Ladnyi, I. D. Smallpox and Its Eradication (World Health Organization, 1988).
Van Dijck, C. et al. Long-term consequences of monkeypox virus infection or modified vaccinia virus Ankara vaccination in Belgium (MPX-COHORT and POQS-FU-PLUS): a 24-month prospective and retrospective cohort study. Lancet Infect. Dis. 26, 190–202 (2025).
Ogoina, D. et al. Case Report: Recurrent mpox in a healthcare worker in Nigeria. Am. J. Trop. Med. Hyg. https://doi.org/10.4269/ajtmh.23-0232 (2023).
Li, T., Li, Z., Xia, Y., Long, J. & Qi, L. Mpox reinfection: a rapid systematic review of case reports. Infect. Med. 3, 100096 (2024).
Hazra, A. et al. Mpox in people with past infection or a complete vaccination course: a global case series. Lancet Infect. Dis. 24, 57–64 (2024).
Okoli, G. N., Van Caeseele, P., Askin, N. & Abou-Setta, A. M. A global systematic evidence review with meta-analysis of the epidemiological characteristics of the 2022 mpox outbreaks. Infection 52, 901–921 (2024).
Bugeme, P. M. et al. Community transmission of mpox clade Ib not driven through sexual exposures, uvira, eastern Democratic Republic of the Congo, June to October 2024. Eurosurveillance 30, 2500280 (2025).
Adler, H. et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect. Dis. 22, 1153–1162 (2022).
Huhn, G. D. et al. Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin. Infect. Dis. 41, 1742–1751 (2005).
Ogoina, D. et al. Clinical characteristics and predictors of human mpox outcome during the 2022 outbreak in Nigeria: a cohort study. Lancet Infect. Dis. https://doi.org/10.1016/S1473-3099(23)00427-9 (2023).
Rojas-Carabali, W., Cifuentes-González, C., Agrawal, R. & de-la-Torre, A. Spectrum of ophthalmic manifestations in monkeypox virus infection worldwide: systematic review and meta-analysis. Heliyon 9, e18561 (2023).
Badenoch, J. B. et al. Neurological and psychiatric presentations associated with human monkeypox virus infection: a systematic review and meta-analysis. eClinicalMedicine 52, 101644 (2022).
Jaleel, A., Farid, G., Irfan, H., Mahmood, K. & Baig, S. A systematic review on the mental health status of patients infected with monkeypox virus. J. Korean Acad. Child Adolesc. Psychiatry 35, 107–118 (2024).
Grau-Echevarría, A. et al. Prospective observational study on scar sequelae after MPOX infection: an analysis of 40 patients. Int. J. Dermatol. 63, 1767 (2024).
Prasad, S. et al. A dermatologic assessment of 101 mpox (monkeypox) cases from 13 countries during the 2022 outbreak: skin lesion morphology, clinical course, and scarring. J. Am. Acad. Dermatol. 88, 1066 (2023).
D’Antonio, F., Pagani, G., Buca, D. & Khalil, A. Monkeypox infection in pregnancy: a systematic review and metaanalysis. Am. J. Obstet. Gynecol. MFM 5, 100747 (2022).
Ogoina, D., Damon, I. & Nakoune, E. Clinical review of human mpox. Clin. Microbiol. Infect. 29, 1493–1501 (2023).
Clinical management of mpox (monkeypox). World Health Organization https://www.who.int/teams/health-care-readiness/clinical-management-of-monkeypox (2022).
Shamim, M. A. et al. The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review. Int. J. Infect. Dis. 127, 150 (2022).
Grosenbach, D. W. & Hruby, D. E. Preliminary screening and in vitro confirmation of orthopoxvirus antivirals. Methods Mol. Biol. 2023, 143–155 (2019).
Grosenbach, D. W. et al. Oral tecovirimat for the treatment of smallpox. N. Engl. J. Med. 379, 44–53 (2018).
Postal, J. et al. Antiviral activity of tecovirimat against monkeypox virus clades 1a, 1b, 2a, and 2b. Lancet Infect. Dis. 25, e126–e127 (2025).
Shabil, M. et al. Effectiveness of tecovirimat in mpox cases: a systematic review of current evidence. J. Med. Virol. 96, e70122 (2024).
Thet, A. K. et al. The use of vaccinia immune globulin in the treatment of severe mpox. Virus infection in human immunodeficiency virus/AIDS. Clin. Infect. Dis. 76, 1671–1673 (2023).
Malik, S., Ahmad, T., Ahsan, O., Muhammad, K. & Waheed, Y. Recent developments in mpox prevention and treatment options. Vaccines 11, 500 (2023).
Mason, L. M. K., Betancur, E., Riera-Montes, M., Lienert, F. & Scheele, S. MVA-BN vaccine effectiveness: a systematic review of real-world evidence in outbreak settings. Vaccine 42, 126409 (2024).
Payne, A. B. et al. Incidence of monkeypox among unvaccinated persons compared with persons receiving ≥1 JYNNEOS vaccine dose — 32 U.S. jurisdictions, July 31–September 3, 2022. Morb. Mortal. Wkly Rep. 71, 1278–1282 (2022).
Kobiyama, K. et al. Immunological analysis of LC16m8 vaccine: preclinical and early clinical insights into mpox. eBioMedicine 115, 105703 (2025).
Shafaati, M. et al. Current advances and challenges in mpox vaccine development: a global landscape. Ther. Adv. Vaccines Immunother. 13, 1–17 (2025).
Poland, G. A., Kennedy, R. B. & Tosh, P. K. Prevention of monkeypox with vaccines: a rapid review. Lancet Infect. Dis. 22, e349–e358 (2022).
World Health Organization. Vaccines and Immunization for Monkeypox: Interim Guidance, 16 November 2022 (WHO, 2022).
Abdul-Rahman, T. et al. Potential of MRNA vaccines for mpox prevention: current evidence and future directions. Ann. Med. Surg. 87, 5650–5660 (2025).
World Health Organization. Mpox Global Strategic Preparedness and Response Plan – April 2025 (WHO, 2025).
Xiridou, M. et al. Combining mpox vaccination and behavioural changes to control possible future mpox resurgence among men who have sex with men: a mathematical modelling study. BMJ Public Health 3, e002682 (2025).
Prochazka, M. et al. Temporary adaptations to sexual behaviour during the mpox outbreak in 23 countries in Europe and the Americas: findings from a retrospective cross-sectional online survey. Lancet Infect. Dis. 24, 1309–1318 (2024).
Maniscalco, D. et al. Adaptive behavior in response to the 2022 mpox epidemic in the Paris region. Preprint at medRxiv https://doi.org/10.1101/2024.10.25.24315987 (2024).
Taylor, L. WHO declares mpox emergency over but says threat remains. BMJ 390, r1908 (2025).
Arita, I. & Henderson, D. A. Smallpox and monkeypox in non-human primates. Bull. World Health Organ. 39, 277–283 (1968).
Arita, I. et al. Outbreaks of monkeypox and serological surveys in nonhuman primates. Bull. World Health Organ. 46, 625–631 (1972).
Breman, J. G., Bernadou, J. & Nakano, J. H. Poxvirus in West African nonhuman primates: serological survey results. Bull. World Health Organ. 55, 605–612 (1977).
Jezek, Z. et al. Human monkeypox: a study of 2,510 contacts of 214 patients. J. Infect. Dis. 154, 551–555 (1986).
Centers for Disease Control and Prevention (CDC) Update: Multistate outbreak of monkeypox — Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. Morb. Mortal. Wkly Rep. 52, 561–564 (2003).
Reynolds, M. G. et al. Spectrum of infection and risk factors for human monkeypox, United States, 2003. Emerg. Infect. Dis. 13, 1332–1339 (2007).
Amisi Kengea, L. et al. Profile of mpox cases identified during surveillance of the Kokolo health zone in Kinshasa (DRC) from August to November 2024. Med. Trop. Sante Int. 5, mtsi.v5i1 (2025).
